Advances in the management and understanding of autoimmune lymphoproliferative syndrome – ALPS
Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of T cell dysregulation caused by defective Fasmediated apoptosis. Patients with
Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of T cell dysregulation caused by defective Fasmediated apoptosis. Patients with
Marcie Tomblyn, Tom Chiller, Hermann Einsele, Ronald Gress, Kent Sepkowitz, Jan Storek, John R. Wingard, Jo-Anne H. Young, Michael
Diabetes mellitus and cardiomyopathy are common in chronically transfused thalassemia major patients, occurring in the second and third decades of life.
da Silva, N. S., Cappellano, A. M., Diez, B. , Cavalheiro, S. , Gardner, S. , Wisoff, J.
Atypical haemolytic uraemic syndrome (aHUS) is associated with a poor prognosis with regard to survival at presentation, recovery of
This article discusses how we approach medical decision making in the treatment of the various facets of the antiphospholipid syndrome
The guideline group was selected to be representative of UKbased medical experts, experienced district general hospital haematologists and a patient
Ferritin has a central role in iron homeostasis since it binds and sequesters intracellular iron. It is a
Prof Richard G Grundy, MBChB, Sophie A Wilne, MBBS, Claire L Weston, MSc, Kath Robinson, BA, Linda S Lashford, MBBS, Prof James Ironside,
Amar Gajjar et al., Lancet Oncol 2006; 7: 813–20
נותנות החסות לאיגוד: